Citeline Podcasts

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。

今回取り上げた記事はこちら:

China Rush Over? Korean Firms Step Up To Seize Opportunities

（邦題意訳「中国企業ブームに続くか？国際進出を強める韓国企業たち」）

https://scrip.pharmaintelligence.informa.com/SC146600/China-Rush-Over-Korean-Firms-Step-Up-To-Seize-Opportunities

【コンサルティングサービスのご紹介】

ファーマインテリジェンスのコンサルティングチームは、製薬やバイオ技術、医療機器といった分野で活躍する企業のお客様と緊密に連携し、個別の課題をピンポイントで解決します。開発途中の薬剤に関するビジネス機会評価や売上予測、価格予測をはじめ、医療経済評価モデルや臨床試験計画、ベンチマークの策定、協業戦略の策定やポートフォリオの優先順位評価など、幅広いニーズに応え、エビデンスに基づいた意思決定を支援します。今解決したい課題をお持ちの方、ぜひご相談ください。

担当者：今堀 逸太郎（[email protected]）

Scrip’s Five Must-Know Things – 4 July 2022 by Citeline

ImmunoACT CEO Dr Rahul Purwar outlines progress made by the firm’s early-stage CAR-T therapy in India, which he believes can be available at a tenth of the price of current on-market treatments or around the cost range for bone marrow transplant. Laurus Labs, which holds about 27% in ImmunoACT, is expected to help shape the firm’s globalization plans.

https://scrip.pharmaintelligence.informa.com/SC146616/Whats-Next-At-Dr-Reddys-Biologics-CDMO-Cell-And-Gene-Therapy-Push

https://scrip.pharmaintelligence.informa.com/SC125979/Early-Indian-Promise-For-A-Cut-Price-CAR-T-Therapy

https://scrip.pharmaintelligence.informa.com/SC125879/Gene-And-Cell-Therapies-In-Asia-Indian-Environment-Evolving-But-Multiple-Issues-Unresolved

https://scrip.pharmaintelligence.informa.com/SC144368/Dr-Reddys-Pilots-Sputnik-V-Soft-Launch-In-India-Explores-CART-Space

On this episode, HBW speaks to Victoria Nichols, project director of Free the Pill. Operated by Ibis Reproductive Health, a nonprofit advocacy organization focused on advancing sexual and reproductive autonomy worldwide, Free the Pill is a campaign supporting increased oral contraceptive access through OTC birth control pills. Ibis Reproductive is also working with Perrigo to submit an Rx-to-OTC switch NDA later this year for its progestin daily oral contraceptive.

In the wake of the Supreme Court’s decision to overturn Roe v. Wade on June 24, Nichols talks about the importance of advocating for OTC birth control, the limited availability of OTC oral contraceptives in the US, and the current legislation being introduced that would help ensure OTC birth control is covered by insurance.

Scrip’s Five Must-Know Things – 27 June 2022 by Citeline

Medtech Monthly is here! Check out the first episode of our new podcast series: It's a knock-down (not really), drag-out (not really), freewheelin' (very much so) conversation about quality versus compliance, with the US FDA's Cisco Vicenty in one corner, and former FDA compliance chief Steve Silverman in the other.

Medtech Insight articles addressing topics discussed in this episode:

• Speaking Of Medtech, Ep. 9: The Case For Compliance

• Speaking Of Medtech, Ep. 8: Medical Device Quality

• Opinion: The Case For Quality – AND Compliance

• Quality Control & Compliance

Datamonitor Healthcare’s oncology team discuss key results from ASCO 2022

Supporting links:

post-ASCO report

https://service.datamonitorhealthcare.com/hkc/thought-leadership/article239222.ece?sg=article

Other platforms in addition to SoundCloud:

Apple Podcasts -  

https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836

Google Podcasts –

https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU1NDkyOC9zb3VuZHMucnNz

TuneIn –

https://tunein.com/podcasts/Business--Economics-Podcasts/Pharma-Intelligence-Podcasts-p1140128/

Spotify Podcasts –

https://open.spotify.com/show/3DTc3eIh4xI6pVOd6DdO67

In this episode of Report Digest, reporter Barnaby Pickering speaks to analyst Mike Carmody about Meddevicetracker’s recent report on deep brain and Vagus nerve stimulation. The two discuss market players, recent tech developments and future potential for the market.

Scrip Intelligence에 실린 파이낸스 워치 (Finance Watch)기사의 요약 내용으로 글로벌 제약바이오업계가 올해 들어 현금 비중을 늘리고 인력 감축에 나서고 있으며, 올해 1분기 글로벌 시장에서 전체 제약바이오 투자 규모는 줄었지만 벤쳐캐피탈 (VC)의 제약바이오 투자 비중이 압도적으로 증가했다는 내용입니다.

https://scrip.pharmaintelligence.informa.com/SC146403/Finance-Watch-More-Job-Cuts-As-Companies-Prioritize-Cash-Conservation

https://scrip.pharmaintelligence.informa.com/SC146493/Finance-Watch-Venture-Capital-Dominates-Biopharma-Funding-So-Far-In-2022

In this month’s Digital Health roundup, Medtech Insight’s Marion Webb discusses her deep-dive article on menopause with leading experts in this rising industry and Barnaby Pickering highlights UK-based Proximie, which developed a web-based platform that allows surgeons and other clinical experts to collaborate virtually in the operating suite. The company recently raised $80m in a series C round.

Listen to the podcast via the player below:

Medtech Insight articles addressing topics discussed in this episode:

Hot Flash! Menopause May Not Be Sexy, But Investors Are Warming Up To Digital Health Solutions

Digital Operating Theater Company Proximie Garners $80M In SoftBank-Jobs Raise